Alternatively, small molecule inhibitors that target the ERK/MAPK signaling pathway, such as U0126, can effectively cut off the pathway, thereby increasing sensitivity of colorectal tumors to 5-Fu. This evidence concerns the gene MAPK1 and colorectal neoplasm.